Atlas of Genetics and Cytogenetics in Oncology and Haematology


Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

Holoprosencephaly-diencephalic hamartoblastoma (HDH).

Written2007-09Marco Castori, Paola Grammatico
Medical Genetics, Institute of Experimental Medicine, Università La Sapienza, San Camillo-Forlanini Hospital, Rome, Italy

(Note : for Links provided by Atlas : click)
 

Identity

Other namesHoloprosencephaly-diencephalic hamartoblastoma association, Holoprosencephaly-hypothalamic hamartoblastoma, Holoprosencephaly-diencephalic hamartoma
Atlas_Id 10142
Genes implicated inSHH  SOX2  
Note HDH is an extremely rare developmental field defect primarily involving the prosencephalon. The most accredited hypothesis is that the hypothalamic hamartoma formation, which occurs early in embryogenesis, produces a cascading process of subsequent craniofacial defects including holoprosencephaly, microphthalmia, hemifacial microsomia, neuronal migration defects, and brainstem/posterior fossa and meningeal anomalies.
Inheritance The inheritance pattern of HDH is still obscure and probably heterogeneous. Environmental/stochastic causes may also contribute for a significant proportion of cases.

Clinics

Phenotype and clinics HDH equally affects males and females. Nearly 100% of the patients present some features of holoprosencephaly. The spectrum of these anomalies is wide, ranging from alobar holoprosencephaly to microforms, such as isolated single central medial incisive, or cleft palate. The most consistent holoprosencephalic features are hypo/aplasia of the corpus callosum, arhinencephaly and premaxillary agenesis. Unilateral or bilateral microphathalmia and neuronal migration/cortical anomalies are quite common abnormalities. Additional findings include meningeal abnormalities, such as cysts and dysplasia, and brainstem and posterior fossa malformations. The first and second branchial arches derivatives may also be asymmetrically affected leading to a significant clinical overlap with the oculo-auriculo-vertebral spectrum. Fifty to sixty per cent of the patients also show extracephalic features, with an excess of midline and laterality determination abnormalities, thus configuring a polytopic developmental field defect. The axial skeleton is the most commonly involved structure, while heart, kidneys, gastrointestinal tract, genitourinary system and limbs are more rarely affected.
Neoplastic risk On embryological perspective, hypothalamic hamartoma/hamartoblastoma is a malformation, not a true tumor. Other benign growth lesions, including meningeal angiomatosis, frontal lipoma, tongue cyst, epignathus and gum nodules, have been observed in about 20% of the cases. However, no increased risk of malignancies has been reported in HDH patients.
Treatment In those patients who survive (see below), the treatment is usually conservative and symptomatic. Surgical repair could be requested for specific potentially life-treating or disfiguring malformations, such as cleft palate, congenital heart disease and genital anomalies. Invasive treatment of hypothalamic hamartomas is usually requested only in presence of intractable seizures. In this case, the experience is limited to non syndromic hamartomas and therapeutic options include surgical resection by conventional craniotomy, microsurgical technique via transcallosal approach and stereotactic radiofrequency thermocoagulation.
Prognosis HDH usually has a poor prognosis and is lethal in about 50% of the cases. Mental retardation, epilepsy and precocious puberty are quite common complications (50-60%) in the surviving patients.

Cytogenetics

Note In one case a 7q36 terminal deletion was demonstrated, while another patient showed a 69, XXX triploid karyotype. Therefore, although rarely positive, standard karyotype and subtelomeric rearrangement analysis are recommended in all HDH patients.

Genes involved and Proteins

Gene NameSHH
Location 7q36
Note Although mutations of this gene have not yet been identified in HDH, a terminal 7q deletion has been documented in one patient and an additional case, showing single central medial incisive and hypophyseal hamartoma, has been described with SHH heterozygous mutation. These evidences suggest that SHH is a potential candidate-gene for those HDH cases who still lack a known cause (e.g. chromosome imbalance or teratogenic exposure).

Gene NameSOX2
Location 3q26.33
Note A single patient showing a SOX2 heterozygous mutation and presenting with hypothalamic hamartoma, unilateral microphthalmia, hypoplastic anterior hypophysis and corpus callosum has been described. Although the observed phenotype cannot be unambiguously interpreted as an atypical form of holoprosencephaly, future studies are expected to demonstrate a causal relationship between SOX2 mutations and HDH.

Bibliography

Gelastic seizure with tectal tumor, lobar holoprosencephaly, and subependymal nodules: clinical report.
Akman CI, Schubert R, Duran M, Loh J
Journal of child neurology. 2002 ; 17 (2) : 152-154.
PMID 11952080
 
Gelastic epilepsy, hypothalamic hamartoma, precocious puberty, and agenesis of the corpus callosum: a new association.
Alikchanov AA, Petrukhin AS, Mukhin KYu, Nikanorov AYu
Brain & development. 1998 ; 20 (4) : 239-241.
PMID 9661969
 
Hydrolethalus (Salonen-Herva-Norio) syndrome: further clinicopathological delineation.
Anyane-Yeboa K, Collins M, Kupsky W, Maidman J, Malin J, Yeh M
American journal of medical genetics. 1987 ; 26 (4) : 899-907.
PMID 3296755
 
Reassessment of holoprosencephaly-diencephalic hamartoblastoma (HDH) association.
Castori M, Douzgou S, Silvestri E, Encha-Razavi F, Dallapiccola B
American journal of medical genetics. Part A. 2007 ; 143 (3) : 277-284.
PMID 17230485
 
A triploid fetus further expands etiological heterogeneity in holoprosencephaly-diencephalic hamartoblastoma.
Castori M, Silvestri E, Nunnari J, Grammatico P, Dallapiccola B
American journal of medical genetics. Part A. 2007 ; 143 (12) : 1391-1393.
PMID 17497722
 
Congenital hypothalamic hamartoma syndrome: nosological discussion and minimum diagnostic criteria of a possibly familial form.
Encha-Razavi F, Larroche JC, Roume J, Migne G, Delezoide AL, Gonzales M, Mulliez N
American journal of medical genetics. 1992 ; 42 (1) : 44-50.
PMID 1308364
 
Meningeal angiomatosis, arhinencephaly, agenesis of the corpus callosum and large hamartoma of the brain, with neoplasia, in an infant having bilateral nasal proboscis.
GITLIN G, BEHAR AJ
Acta anatomica. 1960 ; 41 : 56-79.
PMID 13705778
 
Pallister-Hall syndrome associated with unbalanced chromosome translocation.
Golabi M, Kuller J, Cox K, KeilmanK, Schonberg S
Am J Med Genet. 1991 ; 49.
 
Hypothalamic hamartoma, gelastic epilepsy, precocious puberty--a diffuse cerebral dysgenesis.
Gulati S, Gera S, Menon PS, Kabra M, Kalra V
Brain & development. 2002 ; 24 (8) : 784-786.
PMID 12453604
 
Congenital hypothalamic hamartoblastoma, hypopituitarism, imperforate anus and postaxial polydactyly--a new syndrome? Part I: clinical, causal, and pathogenetic considerations.
Hall JG, Pallister PD, Clarren SK, Beckwith JB, Wiglesworth FW, Fraser FC, Cho S, Benke PJ, Reed SD
American journal of medical genetics. 1980 ; 7 (1) : 47-74.
PMID 7211952
 
Congenital hypothalamic hamartoma associated with severe midline defect: a developmental field defect. Report of a case.
Hennekam RC, Beemer FA, Van Merrienboer F, Van Ketel BA, Kramer PP
American journal of medical genetics. Supplement. 1986 ; 2 : 45-52.
PMID 3146299
 
Stereotactic radiofrequency thermocoagulation for hypothalamic hamartoma with intractable gelastic seizures.
Homma J, Kameyama S, Masuda H, Ueno T, Fujimoto A, Oishi M, Fukuda M
Epilepsy research. 2007 ; 76 (1) : 15-21.
PMID 17643965
 
Case report and delineation of the congenital hypothalamic hamartoblastoma syndrome (Pallister-Hall syndrome).
Iafolla K, Fratkin JD, Spiegel PK, Cohen MM Jr, Graham JM Jr
American journal of medical genetics. 1989 ; 33 (4) : 489-499.
PMID 2688416
 
Mutations within Sox2/SOX2 are associated with abnormalities in the hypothalamo-pituitary-gonadal axis in mice and humans.
Kelberman D, Rizzoti K, Avilion A, Bitner-Glindzicz M, Cianfarani S, Collins J, Chong WK, Kirk JM, Achermann JC, Ross R, Carmignac D, Lovell-Badge R, Robinson IC, Dattani MT
The Journal of clinical investigation. 2006 ; 116 (9) : 2442-2455.
PMID 16932809
 
Hypothalamic hamartoma associated with a craniopharyngeal canal.
Kizilkilic O, Yalcin O, Yildirim T, Sener L, Parmaksiz G, Erdogan B
AJNR. American journal of neuroradiology. 2005 ; 26 (1) : 65-67.
PMID 15661703
 
Pallister-Hall syndrome associated with an unbalanced chromosome translocation.
Kuller JA, Cox VA, Schonberg SA, Golabi M
American journal of medical genetics. 1992 ; 43 (3) : 647-650.
PMID 1605268
 
Hamartoma of the hypothalamus; report of two cases with associated developmental defects.
MARCUSE PM, BURGER RA, SALMON GW
The Journal of pediatrics. 1953 ; 43 (3) : 301-308.
PMID 13085273
 
Bilateral nasal proboscis associated with unilateral anophthalmia, unilateral diffuse pigmentation of the conjunctiva, and anomalies of the skull and brain.
ROSEN Z, GITLIN G
A.M.A. archives of otolaryngology. 1959 ; 70 : 545-550.
PMID 14438899
 
Single median maxillary central incisor, hypophyseal tumor, and SHH mutation.
Ribeiro LA, Richieri-Costa A
American journal of medical genetics. Part A. 2005 ; 136 (4) : 346-347.
PMID 15942953
 
Diencephalic neuronal hamartoma associated with congenital obstructive hydrocephalus, anophthalmia, cleft lip and palate and severe mental retardation: a possible new syndrome.
Rossiter JP, Khalifa MM, Nag S
Acta neuropathologica. 2000 ; 99 (6) : 685-690.
PMID 10867803
 
Duplication of the pituitary gland as shown by MR.
Ryals BD, Brown DC, Levin SW
AJNR. American journal of neuroradiology. 1993 ; 14 (1) : 137-139.
PMID 8427075
 
Neonatal hypothalamic hamartoma: a differentiating nonlethal hamartoblastoma.
Saxonhouse MA, Yachnis AT, Burchfield DJ, Quisling R, Sullivan MP, Pincus DW
Journal of neurosurgery. 2005 ; 103 (3 Suppl) : 277-281.
PMID 16238084
 
Epignathus teratoma: report of three cases with a review of the literature.
Vandenhaute B, Leteurtre E, Lecomte-Houcke M, Pellerin P, Nuyts JP, Cuisset JM, Soto-Ares G
The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association. 2000 ; 37 (1) : 83-91.
PMID 10670895
 
Variability versus heterogeneity in syndromal hypothalamic hamartoblastoma and related disorders: review and delineation of the cerebro-acro-visceral early lethality (CAVE) multiplex syndrome.
Verloes A, Gillerot Y, Langhendries JP, Fryns JP, Koulischer L
American journal of medical genetics. 1992 ; 43 (4) : 669-677.
PMID 1621756
 
Syndromal hypothalamic hamartoblastoma with holoprosencephaly sequence, microphthalmia, pulmonary malformations, radial hypoplasia and müllerian regression: further delineation of a new syndrome?
Verloes A, Narcy F, Fallet-Bianco C
Clinical dysmorphology. 1995 ; 4 (1) : 33-37.
PMID 7735503
 
Solitary central maxillary incisor associated with precocious puberty and hypothalamic hamartoma.
Winter WE, Rosenbloom AL, Maclaren NK, Mickle JP
The Journal of pediatrics. 1982 ; 101 (6) : 965-967.
PMID 7143176
 

Citation

This paper should be referenced as such :
Castori, M ; Grammatico, P
Holoprosencephaly-diencephalic hamartoblastoma (HDH)
Atlas Genet Cytogenet Oncol Haematol. 2008;12(5):414-416.
Free journal version : [ pdf ]   [ DOI ]
On line version : http://AtlasGeneticsOncology.org/Tumors/HoloDienHamartoID10142.html


REVIEW articlesautomatic search in PubMed
Last year articlesautomatic search in PubMed


© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Tue Mar 14 13:56:13 CET 2017


Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

For comments and suggestions or contributions, please contact us

jlhuret@AtlasGeneticsOncology.org.